These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33293437)

  • 81. Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer".
    Zucchini G; Quercia S; Zamagni C; Santini D; Taffurelli M; Fanti S; Martoni AA
    Eur J Cancer; 2013 Nov; 49(16):3575-6. PubMed ID: 24011537
    [No Abstract]   [Full Text] [Related]  

  • 82. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
    Sahiner I; Akkas BE; Ucmak Vural G
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potential pitfalls in interpretation of positron emission tomography/computed tomography findings in the thorax.
    Carter BW; Betancourt SL; Viswanathan C; Mawlawi O; Marom EM; Truong MT
    Semin Roentgenol; 2015 Jul; 50(3):210-6. PubMed ID: 26002241
    [No Abstract]   [Full Text] [Related]  

  • 84. Is sucralose ingestion acceptable before 18F-FDG PET/CT imaging?
    Quagliano PV
    J Nucl Med Technol; 2013 Sep; 41(3):182-3. PubMed ID: 23857418
    [No Abstract]   [Full Text] [Related]  

  • 85. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders.
    Haroon A; Zumla A; Bomanji J
    Clin Infect Dis; 2012 May; 54(9):1333-41. PubMed ID: 22431802
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Positron emission tomography.
    Cistaro A; Quartuccio N; Vesco S; Pagani M; Fania P; Donati L; Nobili FM; Duca S; Carrara G; Valentini MC
    Ophthalmology; 2012 Jul; 119(7):1496-7.e1. PubMed ID: 22749089
    [No Abstract]   [Full Text] [Related]  

  • 87. Editorial comment.
    Sagalowsky AI
    Urology; 2014 Feb; 83(2):398-9. PubMed ID: 24468514
    [No Abstract]   [Full Text] [Related]  

  • 88. Reply: To PMID 24468513.
    Mertens LS; Mir MC; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):399. PubMed ID: 24468515
    [No Abstract]   [Full Text] [Related]  

  • 89. Potential role of positron emission tomography/magnetic resonance imaging in gastrointestinal and abdominal malignancies: preliminary experience.
    Teixera SR; Kohan AA; Paspulati RM; Rong R; Herrmann KA
    Semin Roentgenol; 2014 Oct; 49(4):321-33. PubMed ID: 25498229
    [No Abstract]   [Full Text] [Related]  

  • 90. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
    Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J
    Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Acute inflammatory aortitis: utility of hybrid imaging with positron emission tomography/computed tomography in diagnosis and follow-up.
    McWilliams ET; Dickinson KK; Walker DM; Raman V
    Eur Heart J Cardiovasc Imaging; 2012 Feb; 13(2):173. PubMed ID: 21970825
    [No Abstract]   [Full Text] [Related]  

  • 92. The Basic Principles of FDG-PET/CT Imaging.
    Basu S; Hess S; Nielsen Braad PE; Olsen BB; Inglev S; Høilund-Carlsen PF
    PET Clin; 2014 Oct; 9(4):355-70, v. PubMed ID: 26050942
    [TBL] [Abstract][Full Text] [Related]  

  • 93. PET-CT in MM: a new definition of CR.
    Moreau P
    Blood; 2011 Dec; 118(23):5984-5. PubMed ID: 22134907
    [No Abstract]   [Full Text] [Related]  

  • 94. Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects?
    Wang J; Galal A
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):e187-e188. PubMed ID: 31075397
    [No Abstract]   [Full Text] [Related]  

  • 95. Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders.
    Hess S; Madsen PH; Basu S; Høilund-Carlsen PF; Alavi A
    Clin Nucl Med; 2012 Dec; 37(12):1170-2. PubMed ID: 23154475
    [No Abstract]   [Full Text] [Related]  

  • 96. Does Integrated PET/MR Have a Role in the Management of Patients with Dementia?
    Chiang GC
    Radiology; 2018 Jul; 288(1):207-208. PubMed ID: 29762097
    [No Abstract]   [Full Text] [Related]  

  • 97. Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics.
    Ren W; Ji B; Guan Y; Cao L; Ni R
    Front Med (Lausanne); 2022; 9():771982. PubMed ID: 35402436
    [TBL] [Abstract][Full Text] [Related]  

  • 98. On the Origin of Hybrid Imaging.
    Lammertsma AA
    J Nucl Med; 2020 Dec; 61(Suppl 2):166S-167S. PubMed ID: 33293437
    [No Abstract]   [Full Text] [Related]  

  • 99. Editorial Overview: Non-invasive molecular imaging: dedicated to the memory of Professor Roger Tsien.
    Adams S; Rao J
    Curr Opin Chem Biol; 2018 Aug; 45():iv-vi. PubMed ID: 30075836
    [No Abstract]   [Full Text] [Related]  

  • 100.
    Fowler JS
    J Nucl Med; 2020 Dec; 61(Suppl 2):105S-106S. PubMed ID: 33293430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.